Seong-Eun Ryu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seong-Eun Ryu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bok-Man Kang
Sungkyunkwan University, Department of Biomedical Engineering (BME), Suwon, Republic of Korea
1 shared publication - Hyun-Kyoung Lim
Institute for Basic Science (IBS), Center for Neuroscience Imaging Research (CNIR), Suwon, Republic of Korea
1 shared publication - Juheon Lee
Department of Biomedical Engineering Sungkyunkwan University Suwon Republic of Korea
1 shared publication - Kayoung Han
Institute for Basic Science (IBS), Center for Neuroscience Imaging Research (CNIR), Suwon, Republic of Korea
1 shared publication - Mina Suh
Department of Biomedical Engineering Sungkyunkwan University (SKKU) Suwon Republic of Korea
1 shared publication - Seung Won Chung
Department of Biomedical Engineering Sungkyunkwan University (SKKU) Suwon Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 October 2025
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 12 (04) , 045004-22
Real-time single-vessel analysis reveals vascular-type-dependent blood–brain barrier dysfunction in rodent models of status epilepticus and neuroinflammation
The blood–brain barrier (BBB) plays a central role in maintaining central nervous system (CNS) homeostasis by tightly regulating the exchange of substances between blood and brain parenchyma.1 – 3 Under physiological conditions, the BBB acts as a selective barrier that prevents circulating neurotoxins and immune cells from infiltrating the brain. Recent studies have indicated that the BBB is not a uniform structure. Instead, it displays heterogeneity across brain regions.4,5 Specifically, this heterogeneity in the BBB composition is highly dependent on the types of blood vessels, i.e., from arteries to capillaries to veins.6,7 Emerging research using single-cell RNA sequencing (scRNA-seq) has revealed distinct transcriptional patterns across arterial, capillary, and venous endothelial cells, indicating that each vascular type possesses unique functional characteristics.8 Under pathological conditions such as Alzheimer’s disease, these transcriptomic differences across vascular types are further amplified, with cell-type-specific dysregulation playing a key role in exacerbating BBB dysfunction.9,10 Given the functional specialization of each vascular segment, such molecular alterations are likely to manifest as vessel-type-specific changes in BBB permeability. This suggests that vascular-type-specific BBB dysfunction might drive heterogeneous permeability alterations during disease progression. Although previous studies have provided valuable molecular insights through gene and protein profiling, these approaches alone are insufficient to characterize the functional integrity of the BBB, particularly its permeability properties, which depend on disease stages. It remains unclear how such molecular profiles translate into actual changes in barrier function across vascular types. Therefore, direct and quantitative assessment of BBB leakage at the single-vessel level is essential for linking molecular alterations to functional outcomes. This approach is not only critical for understanding vessel-specific BBB disruption mechanisms but also essential for evaluating the efficacy of targeted therapeutic strategies in a disease-specific manner.
- 1 October 2025
- Published by SPIE-Intl Soc Optical Eng in Neurophotonics
- Vol. 12 (04) , 045004-22
Open AccessReal-time single-vessel analysis reveals vascular-type-dependent blood–brain barrier dysfunction in rodent models of status epilepticus and neuroinflammation
The blood–brain barrier (BBB) plays a central role in maintaining central nervous system (CNS) homeostasis by tightly regulating the exchange of substances between blood and brain parenchyma.1 – 3 Under physiological conditions, the BBB acts as a selective barrier that prevents circulating neurotoxins and immune cells from infiltrating the brain. Recent studies have indicated that the BBB is not a uniform structure. Instead, it displays heterogeneity across brain regions.4,5 Specifically, this heterogeneity in the BBB composition is highly dependent on the types of blood vessels, i.e., from arteries to capillaries to veins.6,7 Emerging research using single-cell RNA sequencing (scRNA-seq) has revealed distinct transcriptional patterns across arterial, capillary, and venous endothelial cells, indicating that each vascular type possesses unique functional characteristics.8 Under pathological conditions such as Alzheimer’s disease, these transcriptomic differences across vascular types are further amplified, with cell-type-specific dysregulation playing a key role in exacerbating BBB dysfunction.9,10 Given the functional specialization of each vascular segment, such molecular alterations are likely to manifest as vessel-type-specific changes in BBB permeability. This suggests that vascular-type-specific BBB dysfunction might drive heterogeneous permeability alterations during disease progression. Although previous studies have provided valuable molecular insights through gene and protein profiling, these approaches alone are insufficient to characterize the functional integrity of the BBB, particularly its permeability properties, which depend on disease stages. It remains unclear how such molecular profiles translate into actual changes in barrier function across vascular types. Therefore, direct and quantitative assessment of BBB leakage at the single-vessel level is essential for linking molecular alterations to functional outcomes. This approach is not only critical for understanding vessel-specific BBB disruption mechanisms but also essential for evaluating the efficacy of targeted therapeutic strategies in a disease-specific manner.